These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6770716)

  • 61. Failure of vitamin B6 to reverse the L-dopa effect in patients on a dopa decarboxylase inhibitor.
    Klawans HL; Ringel SP; Shenker DM
    J Neurol Neurosurg Psychiatry; 1971 Dec; 34(6):682-6. PubMed ID: 5158783
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Aromatic L-amino acid decarboxylase deficiency diagnosed by clinical metabolomic profiling of plasma.
    Atwal PS; Donti TR; Cardon AL; Bacino CA; Sun Q; Emrick L; Reid Sutton V; Elsea SH
    Mol Genet Metab; 2015; 115(2-3):91-4. PubMed ID: 25956449
    [TBL] [Abstract][Full Text] [Related]  

  • 63. How does L-dopa work in parkinsonism?
    Sandler M
    Lancet; 1971 Apr; 1(7703):784. PubMed ID: 4101278
    [No Abstract]   [Full Text] [Related]  

  • 64. Sensitive assay for determination of pyridoxal-5-phosphate in enzymes using high-performance liquid chromatography after derivatization with cyanide.
    Naoi M; Ichinose H; Takahashi T; Nagatsu T
    J Chromatogr; 1988 Dec; 434(1):209-14. PubMed ID: 3243815
    [No Abstract]   [Full Text] [Related]  

  • 65. Determination of 3,4-dihydroxyphenylalanine (DOPA) in plasma and cerebrospinal fluid by high performance liquid chromatography with electrochemical detection.
    Boomsma F; van der Hoorn FA; Man in 't Veld AJ; Schalekamp MA
    Clin Chim Acta; 1988 Nov; 178(1):59-69. PubMed ID: 3147824
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Dopegit in the combined treatment of vitiligo patients].
    Mirakhmedov UM; Rakhmatov BR; Rakhmatov AB; Raimdzhanova MR; Kamzolova KP
    Vestn Dermatol Venerol; 1985 Jun; (6):56-8. PubMed ID: 4036307
    [No Abstract]   [Full Text] [Related]  

  • 67. L-dopa as substrate for human duodenal catechol-O-methyltransferase and aromatic L-amino acid decarboxylase.
    Schultz E
    Biomed Chromatogr; 1990 Nov; 4(6):242-4. PubMed ID: 2289048
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparative and quantitative study of L-dopa decarboxylase mRNA in rat neuronal and non-neuronal tissues.
    Coge F; Krieger-Poullet M; Gros F; Thibault J
    Biochem Biophys Res Commun; 1990 Aug; 170(3):1006-12. PubMed ID: 2390071
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Affinity labeling of pig kidney 3,4-dihydroxyphenylalanine (Dopa) decarboxylase with N-(bromoacetyl)pyridoxamine 5'-phosphate. Modification of an active-site cysteine.
    Dominici P; Maras B; Mei G; Borri Voltattorni C
    Eur J Biochem; 1991 Oct; 201(2):393-7. PubMed ID: 1935936
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Determination of aromatic-L-amino acid decarboxylase in human plasma.
    Boomsma F; van der Hoorn FA; Schalekamp MA
    Clin Chim Acta; 1986 Sep; 159(2):173-83. PubMed ID: 3769207
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of dibutyryl cyclic adenosine 3':5'-monophosphate on the growth of cultured human small-cell lung carcinoma and the specific cellular activity of L-dopa decarboxylase.
    Francis J; Thompson R; Bernal SD; Luk GD; Baylin SB
    Cancer Res; 1983 Feb; 43(2):639-45. PubMed ID: 6293702
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The genetics of dopa decarboxylase in Drosophila melanogaster. I. Isolation and characterization of deficiencies that delete the dopa-decarboxylase-dosage-sensitive region and the alpha-methyl-dopa-hypersensitive locus.
    Wright TR; Hodgetts RB; Sherald AF
    Genetics; 1976 Oct; 84(2):267-85. PubMed ID: 826447
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Reaction of dopa decarboxylase with L-aromatic amino acids under aerobic and anaerobic conditions.
    Bertoldi M; Borri Voltattorni C
    Biochem J; 2000 Dec; 352 Pt 2(Pt 2):533-8. PubMed ID: 11085948
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Automated radiometric assays of enzymatic and nonenzymatic oxidation of DOPA in vitro.
    Tran N
    J Lab Clin Med; 1974 Aug; 84(2):287-91. PubMed ID: 4843233
    [No Abstract]   [Full Text] [Related]  

  • 75. Simultaneous measurement of monoamine metabolites and 5-methyltetrahydrofolate in the cerebrospinal fluid of children.
    Akiyama T; Hayashi Y; Hanaoka Y; Shibata T; Akiyama M; Nakamura K; Tsuyusaki Y; Kubota M; Yoshinaga H; Kobayashi K
    Clin Chim Acta; 2017 Feb; 465():5-10. PubMed ID: 27940130
    [TBL] [Abstract][Full Text] [Related]  

  • 76. L-dopa-resistant Parkinsonism due to dopa decarboxylase deficiency?
    Jankovic J
    Ann Neurol; 1981 Jul; 10(1):64-5. PubMed ID: 7271235
    [No Abstract]   [Full Text] [Related]  

  • 77. The syntheses and substrate specificity for mammalian dihydroxyphenylalanine decarboxylase of 3-, 4-, 5-, and 6-methyl-2-hydroxyphenylalanines and the substrate specificity of 3-, 5-, and 6-methyl-2,4-dihydroxyphenylalanines for the enzyme.
    Bower RH; Lambooy JP
    J Med Chem; 1969 Nov; 12(6):1028-30. PubMed ID: 5351443
    [No Abstract]   [Full Text] [Related]  

  • 78. Dye-sensitized photo-oxidation of pig kidney Dopa decarboxylase.
    Pasqua A; Dominici P; Murgia SM; Poletti A; Borri Voltattorni C
    Biochem Int; 1984 Oct; 9(4):437-46. PubMed ID: 6517952
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Effect of nutrition and environment on noradrenergic metabolism of the central nervous system. II. Nutritional and environmental rehabilitation].
    Castilla-Serna L; Ramírez-López E; Alva-González D; Serrano-Money F; Cravioto J
    Bol Med Hosp Infant Mex; 1988 Sep; 45(9):555-64. PubMed ID: 3190847
    [No Abstract]   [Full Text] [Related]  

  • 80. Metabolism of putative transmitters in individual neurons of Aplysia californica: aromatic amino acid decarboxylase.
    Weinreich D; Dewhurst SA; McCaman RE
    J Neurochem; 1972 Apr; 19(4):1125-30. PubMed ID: 4401683
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.